Schedule 13D ownership disclosure

CERO THERAPEUTICS HLDGS INC

Common Stock, $0.0001 par value per share · CUSIP: 71902K105

Event date: 2025-02-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Atwood-Edminster Trust dtd 4-2-2000

    Shares: 196,074.00 · Class: 6.5%

  • Brian G. AtwoodReported CIK 0001266567

    Shares: 202,404.00 · Class: 6.7%

  • Lynne H. Edminster

    Shares: 196,074.00 · Class: 6.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-011405
Form type
SCHEDULE 13D/A
Filer
ATWOOD BRIAN G
CIK
CIK 1266567
Filed
Feb 07, 2025
Reporting period
Feb 07, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub